X0206 3 2023-07-01 0 0001180262 HERBALIFE LTD. HLF 0001311283 LEVY ROBERT 800 W. OLYMPIC BLVD., SUITE 406 LOS ANGELES CA 90015 0 1 0 0 Regional President - Americas Common Stock 635320 D Stock Appreciation Rights 39.79 2023-12-19 Common Stock 39346 D Stock Appreciation Rights 29.99 2024-04-30 Common Stock 40030 D Stock Appreciation Rights 15.22 2025-03-02 Common Stock 84828 D Stock Appreciation Rights 31.255 2026-05-09 Common Stock 43668 D Stock Appreciation Rights 28.595 2027-02-27 Common Stock 45902 D Stock Appreciation Rights 13.60 2033-05-04 Common Stock 80049 D Balance includes 112,152 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 3,362 were granted on February 19, 2021, of which 20% vested on February 19, 2022, 20% vested on February 19, 2023, and 60% will vest on February 19, 2024; 4,436 were granted on February 25, 2022, of which 20% vested on February 25, 2023, 20% will vest on February 25, 2024, and 60% will vest on February 25, 2025; 94,637 were granted on December 9, 2022 and will vest 100% on December 9, 2024; 11,948 were granted on May 4, 2023, that will vest in 1/3 increments on May 4, 2024, May 4, 2025, and May 4, 2026. All RSU vestings are subject to continued service through each applicable date. Balance also includes 142,740 vested RSUs previously granted to the Reporting Person, which he has elected to defer. These stock appreciation rights were fully vested as of June 21, 2016. These stock appreciation rights were fully vested as of April 30, 2017. These stock appreciation rights were fully vested as of March 2, 2018. These stock appreciation rights were fully vested as of May 9, 2019. These stock appreciation rights were fully vested as of February 27, 2020. On May 4, 2023, the reporting person was granted 80,049 stock appreciation rights that will vest in 1/3 increments on May 4, 2024, May 4, 2025, and May 4, 2026. Alaaeddine Sahibi, as Attorney-In-Fact for Robert Levy 2023-07-10